Company profile
Vibe Growth Corporation
OTC: VIBEF · Healthcare · Drug Manufacturers - Specialty & Generic
#566 of 1,418 Healthcare companies by revenue74th-percentile growth
EA Score
58CFH 61DQ —GM 58SS 39
v0.1 · 45/100 weight · provisional
↑ Piotroski F, operating margin · ↓ balance-sheet leverage, listing tenure
Methodology →Revenue TTM
$18.1M
Rev growth YoY (TTM)
+36.0%
Net income (FY)
-$2.5M
Employees
110
as of 2026-08-27
Market cap
$421.1k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$17.5M$17.5M2025
Net income-$2.5M-$2.5M2025
Operating income$461.8k$461.8k2025
Total assets$11.0M$11.0M2025
Liabilities$18.6M$18.6M2025
Equity-$7.6M-$7.6M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Vibe Growth Corporation’s revenue?
Vibe Growth Corporation booked $17.5M in FY2025 revenue, growing 38% year over year — faster than most Healthcare companies we track, at a -14.0% net margin.
Peers · Healthcare
Marpai, Inc.34DResponse Genetics, Inc——ManifestSeven Holdings Corporation——Micron Solutions, Inc.——Vivos Therapeutics, Inc.38DClever Leaves Holdings Inc.——Neighbors
Sacramento →Key facts
CEOMark William Waldron
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersSacramento, CA
ExchangeOTC: VIBEF
Employees110
IPO date2021-01-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.